Passionately people-centric

And yes, we’ve always been that way.

Our Past

Our Present

Our Future

From our initial founding, Sabai has protected the safety, rights and welfare of those who participate in clinical trials and those that conduct the research.

We began by providing biosafety services and oversight for institutions, and our uniquely personal approach to deep expertise and white-glove service soon drove expansion into IRB review and consulting.

Today, we deliver a complete suite of services to our pharmaceutical and institution partners.

We originated to support the fields of cell and gene therapy, infectious disease, rare disease, and oncology.

Today, we support sponsors and sites across all phases of research and all therapeutic areas, including biologics, human factors, devices, and social behavioral research.

We’re proud to always remain a people-focused company. Through this principle we serve as a true partner to our clients—Sponsors, CROs, institutions, and sites—thoughtfully and expertly curating the best solutions to meet your needs, with highest standards of quality and compliance throughout the clinical trial process.

meet the

Executive Team

Mike Keens

Chief Executive Officer

CONTACT      BIO      LINKEDIN

Dawn Pope

Chief Operating Officer

CONTACT      BIO      LINKEDIN

Chris Jenkins

Founder, Chief Scientific Officer

CONTACT      BIO      LINKEDIN

Melanie Gill

Chief Commercial Officer

CONTACT      BIO      LINKEDIN

Austin Read

Austin Read

Chief Financial Officer

CONTACT      BIO      LINKEDIN

meet the

Service Leaders

Melissa Fink

Senior Director, IRB

CONTACT      BIO     LINKEDIN

Garry Coulson

Director, Regulatory

CONTACT      BIO     LINKEDIN

Jessica Poole

Director, IBC

CONTACT      BIO     LINKEDIN

Megan Aiken

Director, Client Services

CONTACT      BIO     LINKEDIN

Our Collaborators